Apellis Pharmaceuticals, Inc. (APLS) vs Blueprint Medicines Corporation (BPMC)
Detailed comparison between Apellis Pharmaceuticals, Inc., Blueprint Medicines Corporation.Total Return (%)
Apellis Pharmaceuticals, Inc. (APLS)Blueprint Medicines Corporation (BPMC)
Which stock do you think will perform better?
Apellis Pharmaceuticals, Inc.
APLS
Blueprint Medicines Corporation
BPMC
| Metric | Apellis Pharmaceuticals, Inc. (APLS) | Blueprint Medicines Corporation (BPMC) |
|---|---|---|
| Current Price | $27.25 | $91.84 |
| Change | -0.27 (-0.98%) | -0.41 (-0.44%) |
| Market Cap | $3.39B | $5.87B |
| Trailing P/E | 0.00 | 0.00 |
| Forward P/E | -32.44 | -97.70 |
| Dividend Yield | 0.00% | 0.00% |
| 52-Week High | $71.90 | $121.90 |
| 52-Week Low | $24.34 | $80.67 |
| Beta | 0.00 | 0.00 |
| Earnings Per Share | $-2.03 | $-1.07 |
Processing data. Please try again later.
Average Return
| Symbol | 1 Month | Year-to-date | 1 Year | 5 Years | 10 Years | Max |
|---|---|---|---|---|---|---|
| APLS | -8.53% | -8.53% | -62.01% | -21.04% | 94.23% | 94.23% |
| BPMC | -19.35% | -19.35% | -3.38% | 54.98% | 386.70% | 386.70% |